X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Wockhardt with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs TEVA PHARMA (Israel) - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 WOCKHARDT LTD.   TEVA PHARMA
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
TEVA PHARMA
Dec-13
WOCKHARDT LTD./
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,1292,848-   
Low Rs6272,474-   
Sales per share (Unadj.) Rs363.11,634.2-  
Earnings per share (Unadj.) Rs-20.4102.1-  
Cash flow per share (Unadj.) Rs-7.0234.2-  
Dividends per share (Unadj.) Rs10.0089.37-  
Dividend yield (eoy) %1.13.4 33.9%  
Book value per share (Unadj.) Rs301.81,815.3-  
Shares outstanding (eoy) m110.55848.00-   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.41.6 148.5%   
Avg P/E ratio x-42.926.1 -164.8%  
P/CF ratio (eoy) x-125.911.4 -1,108.0%  
Price / Book Value ratio x2.91.5 198.5%  
Dividend payout %-48.987.5 -55.9%   
Avg Mkt Cap Rs m97,0632,256,172 4.3%   
No. of employees `0006.844.9 15.1%   
Total wages/salary Rs m9,6650-   
Avg. sales/employee Rs Th5,931.830,833.7 19.2%   
Avg. wages/employee Rs Th1,428.10-   
Avg. net profit/employee Rs Th-334.01,926.2 -17.3%   
INCOME DATA
Net Sales Rs m40,1461,385,821 2.9%  
Other income Rs m1,1430-   
Total revenues Rs m41,2891,385,821 3.0%   
Gross profit Rs m128379,508 0.0%  
Depreciation Rs m1,489112,017 1.3%   
Interest Rs m2,25327,220 8.3%   
Profit before tax Rs m-2,472240,271 -1.0%   
Minority Interest Rs m01,092 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-157,725 0.0%   
Tax Rs m-211-2,933 7.2%   
Profit after tax Rs m-2,26086,571 -2.6%  
Gross profit margin %0.327.4 1.2%  
Effective tax rate %8.5-1.2 -699.6%   
Net profit margin %-5.66.2 -90.1%  
BALANCE SHEET DATA
Current assets Rs m46,160935,978 4.9%   
Current liabilities Rs m19,258816,252 2.4%   
Net working cap to sales %67.08.6 775.6%  
Current ratio x2.41.1 209.0%  
Inventory Days Days10191 110.9%  
Debtors Days Days9496 98.1%  
Net fixed assets Rs m40,165452,640 8.9%   
Share capital Rs m5533,411 16.2%   
"Free" reserves Rs m32,8140-   
Net worth Rs m33,3671,539,384 2.2%   
Long term debt Rs m31,903708,601 4.5%   
Total assets Rs m89,6873,167,045 2.8%  
Interest coverage x-0.19.8 -1.0%   
Debt to equity ratio x1.00.5 207.7%  
Sales to assets ratio x0.40.4 102.3%   
Return on assets %03.6 -0.2%  
Return on equity %-6.85.6 -120.5%  
Return on capital %-0.34.9 -6.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m6,9880-   
CASH FLOW
From Operations Rs m-2,695220,828 -1.2%  
From Investments Rs m-6,863-78,248 8.8%  
From Financial Activity Rs m12,545-264,898 -4.7%  
Net Cashflow Rs m3,010-122,318 -2.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 68.22 Rs / USD

Compare WOCKHARDT LTD. With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare WOCKHARDT LTD. With: ALEMBIC PHARMA  TTK HEALTHCARE  STRIDES SHASUN LTD  AJANTA PHARMA  DISHMAN PHARMA  



Today's Market

Sensex Ends Volatile Day in Red; Pharma Stocks Lose Most(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a negative note.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Jun 21, 2018 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. - ASTRAZENECA PHARMA COMPARISON

COMPARE WOCKHARDT LTD. WITH

MARKET STATS